Abstract:
A polypeptide porous body of the present invention is a porous body of a polypeptide derived from spider silk proteins. The polypeptide includes a water-insoluble polypeptide. The polypeptide porous body has an apparent density of 0.1 g/cm3 or less. A method for producing the polypeptide porous body includes: a solution production step in which the polypeptide is dissolved in at least one solvent selected from DMSO, DMF, and these with an inorganic salt, so as to obtain a solution of the polypeptide; a step in which the solution produced in the solution production step is substituted with a water-soluble solvent so as to obtain a polypeptide gel; and a step in which the polypeptide gel is dried. Thereby, the present invention provides a polypeptide porous body having excellent water absorbability and a polypeptide porous body suitable for application to a living body, and a method for producing the same.
Abstract:
The present invention relates to a method for preparing a nerve conduit containing cells, more particularly to a method for preparing a porous nerve conduit containing cells, having micropores formed in microchannels, wherein the nerve conduit containing cells prepared according to the present invention can be usefully used in in-vitro and in-vivo researches on nerves.
Abstract:
A porous membrane is made from a poly(phenylene ether) copolymer containing 10 to 40 mole percent repeat units derived from 2-methyl-6-phenylphenol and 60 to 90 mole percent repeat units derived from 2,6-dimethylphenol; and a block copolymer containing backbone or pendant blocks of poly(C2-4 alkylene oxide). The porous membrane is made by dissolving the poly(phenylene ether) copolymer in a water-miscible polar aprotic solvent to form a membrane-forming composition; and phase-inverting the membrane forming-composition in a first non-solvent composition to form the porous membrane. A method of making a hollow fiber by coextrusion through a spinneret having an annulus and a bore, includes coextruding the membrane-forming composition through the annulus, and a first non-solvent composition through the bore, into a second non-solvent composition to form the hollow fiber.
Abstract:
A polymer composition containing a polymer (B) obtained by polymerizing a monomer composition containing: a methacrylic acid ester macromonomer (b1) represented by the following formula (1); and another monomer (b2). Also, a porous membrane formed from a membrane forming polymer (A) and the aforementioned polymer composition.
Abstract:
The present invention aims to provide a porous polymer membrane that is excellent not only in water permeability and alkali resistance but also in mechanical strength. The porous polymer membrane of the present invention includes a fluoropolymer (A) that includes a vinylidene fluoride unit and a tetrafluoroethylene unit.
Abstract:
A polypeptide porous body of the present invention is a porous body of a polypeptide derived from spider silk proteins. The polypeptide includes a water-insoluble polypeptide. The polypeptide porous body has an apparent density of 0.1 g/cm3 or less. A method for producing the polypeptide porous body includes: a solution production step in which the polypeptide is dissolved in at least one solvent selected from DMSO, DMF, and these with an inorganic salt, so as to obtain a solution of the polypeptide; a step in which the solution produced in the solution production step is substituted with a water-soluble solvent so as to obtain a polypeptide gel; and a step in which the polypeptide gel is dried. Thereby, the present invention provides a polypeptide porous body having excellent water absorbability and a polypeptide porous body suitable for application to a living body, and a method for producing the same.
Abstract:
The invention relates to the production of microspheres having radial pores using thermally induced phase separation, especially microspheres for use in tissue engineering.
Abstract:
A fluoropolymer including a vinylidene fluoride unit, a tetrafluoroethylene unit, and a unit represented by the following formula (1): —CHX1—CX2(OR)- (1) wherein one of X1 and X2 is a hydrogen atom, and the other is a fluorine atom; and R is a hydrogen atom or a C1-C8 alkyl group.